Sanofi Secures China Rights to RNAi Candidate for Hypertriglyceridemia from Arrowhead
In a major regional licensing agreement, Sanofi has entered into an asset purchase deal with Visirna Therapeutics, a majority-owned subsidiary
Read more
RNA
The Growing Importance of RNA Sequencing in Drug Discovery
Advanced single-cell technologies, particularly methods such as single-cell RNA sequencing (scRNA-seq), coupled with sophisticated computational tools and the increasing accessibility
Read more
Lilly’s Lepodisiran Slashes Heart Disease Risk Factor by 94% in Phase 2 Trial
Eli Lilly and Company announced groundbreaking Phase 2 results for its investigational siRNA therapy lepodisiran, which reduced lipoprotein(a) [Lp(a)] levels
Read more
Massive AI Model Trained on 9.3 Trillion Nucleotides Now Publicly Available
Researchers and scientists worldwide can now access Evo 2, a massive new foundation model that deciphers the genetic code across
Read more
Rapid Viral RNA/DNA Extraction Kits | SARS-CoV-2
BioEcho has developed a new range of rapid viral RNA/DNA extraction kits designed for a one-step extraction of viral RNA
Read more
Non-toxic Recovery of Cells from Dextran Gels
3-D Life Dextranase developed by Cellendes allows non-toxic recovery of cells from dextran-based 3-D Life Hydrogels without harming the cells
Read more
Merck KGaA Invests € 300m for New Research Centre in Darmstadt, Germany
Merck KGaA (Merck) announced an investment today of more than €300 Million ($320.8m) in a new Life Science Research Centre
Read more
Nutcracker’s mRNA Drug Candidate for Prostate Cancer Effectively Targets CD3 T cells
Preclinical data shows that Nutcracker’s mRNA drug candidate NTX-470 effectively targets CD3 T cells, demonstrating selective engagement with minimal unintended
Read more
Pfizer Enters $331 Million RNA Discovery Collaboration with Ginkgo Bioworks
American biotech company Ginkgo Bioworks announced a new collaboration with Pfizer focused on the discovery of RNA-based drug candidates. The
Read more
Merck KGaA to Become the First CTDMO Offering Fully Integrated mRNA Services
In a significant milestone for the pharmaceutical industry, Merck KGaA has established itself as the pioneer Contract Testing, Development, and
Read more